Decibel Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Decibel Therapeutics

16/03/2023 13:31

* Decibel Therapeutics Inc  DBTX.OQ  reported a quarterly
adjusted
loss of 63 cents​​ per share for the quarter ended in December.
The mean expectation of six analysts for the quarter was for a
loss of 40 cents per share.
    * Reported revenue was zero​; analysts expected $7.50
million. 
    * Decibel Therapeutics Inc's reported EPS for the quarter
was a
loss of 63 cents​.
    * The mean earnings estimate of analysts had fallen by
about 11.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Decibel Therapeutics Inc shares had risen by 71.2% this
quarter.
    * The company reported a quarterly loss of $15.94 million.
    * Wall Street's median 12-month price target for Decibel
Therapeutics Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.40          -0.63          Missed
 Sep. 30 2022      -0.69          -0.64          Beat
 Jun. 30 2022      -0.57          -0.68          Missed
 Mar. 31 2022      -0.56          -0.56          Met